Abstract Virtual memory CD8+ T (TVM) cells, also known as antigen-inexperienced T cells with memory phenotypes, have been reported to mediate bystander protection against primary infection. It is known that the expansion of TVM cells depends largely on IL-4; thus, we used α-galactosylceramide (α-GalCer), which activates invariant natural killer T (iNKT) cells to trigger a strong IL-4 response to expand TVM cells in mice. Whether expanded TVM cells could grant protection against influenza A virus (IAV) and Streptococcus pneumoniae (SPN) infections and the functions of TVM cells in the lungs in these settings remain unknown. Here, we revealed that TVM cells significantly increased in the respiratory tract after α-GalCer treatment and maintained for at least 14 days. In contrast, the percentage of iNKT cells has returned to basal levels at this time. Furthermore, α-GalCer treatment generated more effector functional CD8+ cells and the proportion of TVM cells in the cytokine-producing CD8+ cell population significantly increased in the lungs and mediastinal lymph nodes. Notably, α-GalCer treatment decreased the viral titer after mice were challenged with a high dose of IAV as well as significantly improved the survival of SPN-infected mice. These results suggested that the protection may be attributed to TVM cells. Therefore, we further established a reliable intranasal transfer model to investigate the direct role of TVM cells in pulmonary viral and bacterial infections.
Read full abstract